Compass Pathways plc is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 synthetic psilocybin treatment.
